ID   FAK1_HUMAN              Reviewed;         879 AA.
AC   Q05397-2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   12-OCT-2022, entry version 250.
DE   RecName: Full=Isoform 2 of Focal adhesion kinase 1 {ECO:0000305};
DE            Short=FADK 1;
DE            EC=2.7.10.2;
DE   AltName: Full=Focal adhesion kinase-related nonkinase;
DE            Short=FRNK;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 71;
DE            Short=PPP1R71;
DE   AltName: Full=Protein-tyrosine kinase 2;
DE   AltName: Full=p125FAK;
DE   AltName: Full=pp125FAK;
GN   Name=PTK2 {ECO:0000312|HGNC:HGNC:9611}; Synonyms=FAK, FAK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=T-cell;
RX   PubMed=7692878; DOI=10.1089/dna.1993.12.823;
RA   Whitney G.S., Chan P.Y., Blake J., Cosand W.L., Neubauer M.G., Aruffo A.,
RA   Kanner S.B.;
RT   "Human T and B lymphocytes express a structurally conserved focal adhesion
RT   kinase, pp125FAK.";
RL   DNA Cell Biol. 12:823-830(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8422239; DOI=10.1006/bbrc.1993.1022;
RA   Andre E., Becker-Andre M.;
RT   "Expression of an N-terminally truncated form of human focal adhesion
RT   kinase in brain.";
RL   Biochem. Biophys. Res. Commun. 190:140-147(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-19; 192-199; 222-236; 243-252; 350-364; 414-419;
RP   468-476; 562-569; 674-690; 798-811; 832-838; 904-933; 963-981; 989-1000 AND
RP   1003-1042, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Osteosarcoma;
RA   Bienvenut W.V., Glen H., Brunton V.G., Frame M.C.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 552-602, AND TISSUE SPECIFICITY.
RC   TISSUE=Melanocyte;
RX   PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [8]
RP   FUNCTION, INTERACTION WITH NEDD9, AND MUTAGENESIS OF TYR-397.
RX   PubMed=9360983; DOI=10.1074/jbc.272.46.29083;
RA   Tachibana K., Urano T., Fujita H., Ohashi Y., Kamiguchi K., Iwata S.,
RA   Hirai H., Morimoto C.;
RT   "Tyrosine phosphorylation of Crk-associated substrates by focal adhesion
RT   kinase. A putative mechanism for the integrin-mediated tyrosine
RT   phosphorylation of Crk-associated substrates.";
RL   J. Biol. Chem. 272:29083-29090(1997).
RN   [9]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=9422762; DOI=10.1074/jbc.273.2.1003;
RA   Matsuya M., Sasaki H., Aoto H., Mitaka T., Nagura K., Ohba T., Ishino M.,
RA   Takahashi S., Suzuki R., Sasaki T.;
RT   "Cell adhesion kinase beta forms a complex with a new member, Hic-5, of
RT   proteins localized at focal adhesions.";
RL   J. Biol. Chem. 273:1003-1014(1998).
RN   [10]
RP   INTERACTION WITH TGFB1I1, AND MUTAGENESIS OF VAL-928 AND LEU-1034.
RX   PubMed=9756887; DOI=10.1074/jbc.273.41.26516;
RA   Fujita H., Kamiguchi K., Cho D., Shibanuma M., Morimoto C., Tachibana K.;
RT   "Interaction of Hic-5, A senescence-related protein, with focal adhesion
RT   kinase.";
RL   J. Biol. Chem. 273:26516-26521(1998).
RN   [11]
RP   FUNCTION IN PXN PHOSPHORYLATION; REGULATION OF CELL SHAPE AND MIGRATION,
RP   INTERACTION WITH EPHA2, AUTOPHOSPHORYLATION, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, DEPHOSPHORYLATION BY PTPN11, AND SUBCELLULAR LOCATION.
RX   PubMed=10655584; DOI=10.1038/35000008;
RA   Miao H., Burnett E., Kinch M., Simon E., Wang B.;
RT   "Activation of EphA2 kinase suppresses integrin function and causes focal-
RT   adhesion-kinase dephosphorylation.";
RL   Nat. Cell Biol. 2:62-69(2000).
RN   [12]
RP   FUNCTION IN CELL MIGRATION AND ACTIVATION OF BMX, CATALYTIC ACTIVITY,
RP   AUTOPHOSPHORYLATION, MUTAGENESIS OF TYR-397, AND INTERACTION WITH BMX.
RX   PubMed=11331870; DOI=10.1038/35074500;
RA   Chen R., Kim O., Li M., Xiong X., Guan J.L., Kung H.J., Chen H.,
RA   Shimizu Y., Qiu Y.;
RT   "Regulation of the PH-domain-containing tyrosine kinase Etk by focal
RT   adhesion kinase through the FERM domain.";
RL   Nat. Cell Biol. 3:439-444(2001).
RN   [13]
RP   FUNCTION IN PHOSPHORYLATION OF SHC1, AUTOPHOSPHORYLATION, INTERACTION WITH
RP   SHC1 AND SRC, AND ROLE IN DISEASE.
RX   PubMed=11980671;
RA   Hecker T.P., Grammer J.R., Gillespie G.Y., Stewart J. Jr., Gladson C.L.;
RT   "Focal adhesion kinase enhances signaling through the Shc/extracellular
RT   signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy
RT   samples.";
RL   Cancer Res. 62:2699-2707(2002).
RN   [14]
RP   INTERACTION WITH RB1CC1.
RX   PubMed=12221124; DOI=10.1091/mbc.e02-05-0295;
RA   Abbi S., Ueda H., Zheng C., Cooper L.A., Zhao J., Christopher R.,
RA   Guan J.L.;
RT   "Regulation of focal adhesion kinase by a novel protein inhibitor FIP200.";
RL   Mol. Biol. Cell 13:3178-3191(2002).
RN   [15]
RP   PHOSPHORYLATION AT TYR-397; TYR-407; TYR-577; TYR-861 AND TYR-925, AND
RP   INTERACTION WITH FGR.
RX   PubMed=12387730; DOI=10.1042/bj20020410;
RA   Relou I.A.M., Bax L.A.B., Van Rijn H.J.M., Akkerman J.-W.N.;
RT   "Site-specific phosphorylation of platelet focal adhesion kinase by low-
RT   density lipoprotein.";
RL   Biochem. J. 369:407-416(2003).
RN   [16]
RP   FUNCTION IN INTEGRIN SIGNALING; REGULATION OF APOPTOSIS; REGULATION OF CELL
RP   SHAPE AND ACTIVATION OF PHOSPHATIDYLINOSITOL KINASE AND AKT1 SIGNALING
RP   PATHWAY.
RX   PubMed=15166238; DOI=10.1074/jbc.m313265200;
RA   Xia H., Nho R.S., Kahm J., Kleidon J., Henke C.A.;
RT   "Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in
RT   regulating fibroblast survival in response to contraction of type I
RT   collagen matrices via a beta 1 integrin viability signaling pathway.";
RL   J. Biol. Chem. 279:33024-33034(2004).
RN   [17]
RP   FUNCTION IN REGULATION OF CELL MIGRATION, AND PHOSPHORYLATION AT TYR-407;
RP   TYR-397 AND TYR-576.
RX   PubMed=15561106; DOI=10.1016/j.yexcr.2004.09.005;
RA   Continolo S., Baruzzi A., Majeed M., Caveggion E., Fumagalli L.,
RA   Lowell C.A., Berton G.;
RT   "The proto-oncogene Fgr regulates cell migration and this requires its
RT   plasma membrane localization.";
RL   Exp. Cell Res. 302:253-269(2005).
RN   [18]
RP   INTERACTION WITH P53/TP53, AND SUBCELLULAR LOCATION.
RX   PubMed=15855171; DOI=10.1074/jbc.m414172200;
RA   Golubovskaya V.M., Finch R., Cance W.G.;
RT   "Direct interaction of the N-terminal domain of focal adhesion kinase with
RT   the N-terminal transactivation domain of p53.";
RL   J. Biol. Chem. 280:25008-25021(2005).
RN   [19]
RP   FUNCTION IN FOCAL ADHESION DISASSEMBLY.
RX   PubMed=15895076; DOI=10.1038/ncb1262;
RA   Ezratty E.J., Partridge M.A., Gundersen G.G.;
RT   "Microtubule-induced focal adhesion disassembly is mediated by dynamin and
RT   focal adhesion kinase.";
RL   Nat. Cell Biol. 7:581-590(2005).
RN   [20]
RP   INTERACTION WITH FLT4.
RX   PubMed=16452200; DOI=10.1158/0008-5472.can-05-1661;
RA   Garces C.A., Kurenova E.V., Golubovskaya V.M., Cance W.G.;
RT   "Vascular endothelial growth factor receptor-3 and focal adhesion kinase
RT   bind and suppress apoptosis in breast cancer cells.";
RL   Cancer Res. 66:1446-1454(2006).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   ALTERNATIVE PROMOTER USAGE, IDENTIFICATION OF ISOFORM 6, AND DEVELOPMENTAL
RP   STAGE (ISOFORM 6).
RX   PubMed=16998626; DOI=10.1007/s00795-006-0325-8;
RA   Nagoshi Y., Yamamoto G., Irie T., Tachikawa T.;
RT   "Expression of FAK-related non-kinase (FRNK) coincides with morphological
RT   change in the early stage of cell adhesion.";
RL   Med. Mol. Morphol. 39:154-160(2006).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [24]
RP   ACTIVITY REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION AT TYR-397 AND
RP   TYR-861.
RX   PubMed=18006843; DOI=10.1158/0008-5472.can-07-2667;
RA   Halder J., Lin Y.G., Merritt W.M., Spannuth W.A., Nick A.M., Honda T.,
RA   Kamat A.A., Han L.Y., Kim T.J., Lu C., Tari A.M., Bornmann W.,
RA   Fernandez A., Lopez-Berestein G., Sood A.K.;
RT   "Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in
RT   ovarian carcinoma.";
RL   Cancer Res. 67:10976-10983(2007).
RN   [25]
RP   FUNCTION, ACTIVITY REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION AT
RP   TYR-397.
RX   PubMed=17395594; DOI=10.1074/jbc.m606695200;
RA   Slack-Davis J.K., Martin K.H., Tilghman R.W., Iwanicki M., Ung E.J.,
RA   Autry C., Luzzio M.J., Cooper B., Kath J.C., Roberts W.G., Parsons J.T.;
RT   "Cellular characterization of a novel focal adhesion kinase inhibitor.";
RL   J. Biol. Chem. 282:14845-14852(2007).
RN   [26]
RP   FUNCTION IN OSTEOBLAST DIFFERENTIATION.
RX   PubMed=16927379; DOI=10.1002/jcb.21074;
RA   Salasznyk R.M., Klees R.F., Boskey A., Plopper G.E.;
RT   "Activation of FAK is necessary for the osteogenic differentiation of human
RT   mesenchymal stem cells on laminin-5.";
RL   J. Cell. Biochem. 100:499-514(2007).
RN   [27]
RP   FUNCTION, ACTIVITY REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION AT
RP   TYR-397.
RX   PubMed=17431114; DOI=10.1158/1535-7163.mct-06-0476;
RA   Liu T.J., LaFortune T., Honda T., Ohmori O., Hatakeyama S., Meyer T.,
RA   Jackson D., de Groot J., Yung W.K.;
RT   "Inhibition of both focal adhesion kinase and insulin-like growth factor-I
RT   receptor kinase suppresses glioma proliferation in vitro and in vivo.";
RL   Mol. Cancer Ther. 6:1357-1367(2007).
RN   [28]
RP   FUNCTION, AND INTERACTION WITH LPXN.
RX   PubMed=18497331; DOI=10.1161/circresaha.107.170357;
RA   Sundberg-Smith L.J., DiMichele L.A., Sayers R.L., Mack C.P., Taylor J.M.;
RT   "The LIM protein leupaxin is enriched in smooth muscle and functions as an
RT   serum response factor cofactor to induce smooth muscle cell gene
RT   transcription.";
RL   Circ. Res. 102:1502-1511(2008).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH BMX.
RX   PubMed=18292575; DOI=10.4049/jimmunol.180.5.3485;
RA   Semaan N., Alsaleh G., Gottenberg J.E., Wachsmann D., Sibilia J.;
RT   "Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-
RT   talk between MyD88 and FAK pathways.";
RL   J. Immunol. 180:3485-3491(2008).
RN   [30]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CASS4.
RX   PubMed=18256281; DOI=10.1091/mbc.e07-09-0953;
RA   Singh M.K., Dadke D., Nicolas E., Serebriiskii I.G., Apostolou S.,
RA   Canutescu A., Egleston B.L., Golemis E.A.;
RT   "A novel Cas family member, HEPL, regulates FAK and cell spreading.";
RL   Mol. Biol. Cell 19:1627-1636(2008).
RN   [31]
RP   FUNCTION IN REGULATION OF P53/TP53 LEVELS; CELL PROLIFERATION AND CELL
RP   SURVIVAL, AND SUBCELLULAR LOCATION.
RX   PubMed=18206965; DOI=10.1016/j.molcel.2007.11.031;
RA   Lim S.T., Chen X.L., Lim Y., Hanson D.A., Vo T.T., Howerton K.,
RA   Larocque N., Fisher S.J., Schlaepfer D.D., Ilic D.;
RT   "Nuclear FAK promotes cell proliferation and survival through FERM-enhanced
RT   p53 degradation.";
RL   Mol. Cell 29:9-22(2008).
RN   [32]
RP   INTERACTION WITH ESR1; PIK3R1 AND/OR PIK3R2 AND SRC.
RX   PubMed=18657504; DOI=10.1016/j.molcel.2008.05.025;
RA   Le Romancer M., Treilleux I., Leconte N., Robin-Lespinasse Y., Sentis S.,
RA   Bouchekioua-Bouzaghou K., Goddard S., Gobert-Gosse S., Corbo L.;
RT   "Regulation of estrogen rapid signaling through arginine methylation by
RT   PRMT1.";
RL   Mol. Cell 31:212-221(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-887 AND
RP   SER-910, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [36]
RP   PHOSPHORYLATION AT TYR-397; TYR-576; TYR-577; SER-722; TYR-861 AND TYR-925,
RP   AND IDENTIFICATION IN A COMPLEX WITH CTTN AND FER.
RX   PubMed=19339212; DOI=10.1016/j.bbamcr.2009.01.015;
RA   Oh M.A., Choi S., Lee M.J., Choi M.C., Lee S.A., Ko W., Cance W.G.,
RA   Oh E.S., Buday L., Kim S.H., Lee J.W.;
RT   "Specific tyrosine phosphorylation of focal adhesion kinase mediated by Fer
RT   tyrosine kinase in suspended hepatocytes.";
RL   Biochim. Biophys. Acta 1793:781-791(2009).
RN   [37]
RP   FUNCTION IN SRC-MEDIATED PHOSPHORYLATION OF PXN.
RX   PubMed=19138410; DOI=10.1186/1471-2407-9-12;
RA   Sachdev S., Bu Y., Gelman I.H.;
RT   "Paxillin-Y118 phosphorylation contributes to the control of Src-induced
RT   anchorage-independent growth by FAK and adhesion.";
RL   BMC Cancer 9:12-12(2009).
RN   [38]
RP   INTERACTION WITH STEAP4.
RX   PubMed=19787193; DOI=10.3892/ijmm_00000270;
RA   Tamura T., Chiba J.;
RT   "STEAP4 regulates focal adhesion kinase activation and CpG motifs within
RT   STEAP4 promoter region are frequently methylated in DU145, human androgen-
RT   independent prostate cancer cells.";
RL   Int. J. Mol. Med. 24:599-604(2009).
RN   [39]
RP   INTERACTION WITH EMP2.
RX   PubMed=19494199; DOI=10.1167/iovs.08-3315;
RA   Morales S.A., Mareninov S., Coulam P., Wadehra M., Goodglick L., Braun J.,
RA   Gordon L.K.;
RT   "Functional consequences of interactions between FAK and epithelial
RT   membrane protein 2 (EMP2).";
RL   Invest. Ophthalmol. Vis. Sci. 50:4949-4956(2009).
RN   [40]
RP   FUNCTION IN SRC-MEDIATED PHOSPHORYLATION OF BCAR1, AND ROLE IN DISEASE.
RX   PubMed=19147981; DOI=10.1172/jci37160;
RA   Pylayeva Y., Gillen K.M., Gerald W., Beggs H.E., Reichardt L.F.,
RA   Giancotti F.G.;
RT   "Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires
RT   focal adhesion kinase signaling.";
RL   J. Clin. Invest. 119:252-266(2009).
RN   [41]
RP   INTERACTION WITH EPHA1.
RX   PubMed=19118217; DOI=10.1242/jcs.036467;
RA   Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y.;
RT   "EphA1 interacts with integrin-linked kinase and regulates cell morphology
RT   and motility.";
RL   J. Cell Sci. 122:243-255(2009).
RN   [42]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT TYR-5; THR-13; SER-29; TYR-397; TYR-570; SER-580 AND SER-910,
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [43]
RP   ROLE IN DISEASE, AND ACTIVITY REGULATION.
RX   PubMed=20495381; DOI=10.4161/cbt.10.1.11993;
RA   Sun H., Pisle S., Gardner E.R., Figg W.D.;
RT   "Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study
RT   in PC3M-luc-C6 local implant and metastasis xenograft models.";
RL   Cancer Biol. Ther. 10:38-43(2010).
RN   [44]
RP   INTERACTION WITH LPXN.
RX   PubMed=19917054; DOI=10.1111/j.1349-7006.2009.01398.x;
RA   Tanaka T., Moriwaki K., Murata S., Miyasaka M.;
RT   "LIM domain-containing adaptor, leupaxin, localizes in focal adhesion and
RT   suppresses the integrin-induced tyrosine phosphorylation of paxillin.";
RL   Cancer Sci. 101:363-368(2010).
RN   [45]
RP   FUNCTION (ISOFORM 6), AND TISSUE SPECIFICITY.
RX   PubMed=20109444; DOI=10.1016/j.yexcr.2010.01.021;
RA   Cai G.Q., Zheng A., Tang Q., White E.S., Chou C.F., Gladson C.L.,
RA   Olman M.A., Ding Q.;
RT   "Downregulation of FAK-related non-kinase mediates the migratory phenotype
RT   of human fibrotic lung fibroblasts.";
RL   Exp. Cell Res. 316:1600-1609(2010).
RN   [46]
RP   INTERACTION WITH ZFYVE21, AND DEPHOSPHORYLATION AT TYR-397.
RX   PubMed=20439989; DOI=10.1074/jbc.m110.106443;
RA   Nagano M., Hoshino D., Sakamoto T., Kawasaki N., Koshikawa N., Seiki M.;
RT   "ZF21 protein regulates cell adhesion and motility.";
RL   J. Biol. Chem. 285:21013-21022(2010).
RN   [47]
RP   INTERACTION WITH CD36.
RX   PubMed=20037584; DOI=10.1038/ni.1836;
RA   Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A.,
RA   Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A.,
RA   El Khoury J., Golenbock D.T., Moore K.J.;
RT   "CD36 ligands promote sterile inflammation through assembly of a Toll-like
RT   receptor 4 and 6 heterodimer.";
RL   Nat. Immunol. 11:155-161(2010).
RN   [48]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910 AND THR-914, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [49]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [50]
RP   INTERACTION WITH RET, FUNCTION IN RET PHOSPHORYLATION, AND PHOSPHORYLATION
RP   AT TYR-576 AND TYR-577.
RX   PubMed=21454698; DOI=10.1074/jbc.m110.168500;
RA   Plaza-Menacho I., Morandi A., Mologni L., Boender P.,
RA   Gambacorti-Passerini C., Magee A.I., Hofstra R.M.W., Knowles P.,
RA   McDonald N.Q., Isacke C.M.;
RT   "Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming
RT   a direct and reciprocal RET-FAK transactivation mechanism.";
RL   J. Biol. Chem. 286:17292-17302(2011).
RN   [51]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-843 AND
RP   SER-910, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [52]
RP   INTERACTION WITH CIB1 ISOFORM 2.
RC   TISSUE=Brain;
RX   PubMed=23503467; DOI=10.1038/onc.2013.43;
RA   Armacki M., Joodi G., Nimmagadda S.C., de Kimpe L., Pusapati G.V.,
RA   Vandoninck S., Van Lint J., Illing A., Seufferlein T.;
RT   "A novel splice variant of calcium and integrin-binding protein 1 mediates
RT   protein kinase D2-stimulated tumour growth by regulating angiogenesis.";
RL   Oncogene 33:1167-1180(2014).
RN   [53]
RP   REVIEW ON SIGNALING AND ON DIRECT PTK2/FAK1 SUBSTRATES.
RX   PubMed=10354709; DOI=10.1016/s0079-6107(98)00052-2;
RA   Schlaepfer D.D., Hauck C.R., Sieg D.J.;
RT   "Signaling through focal adhesion kinase.";
RL   Prog. Biophys. Mol. Biol. 71:435-478(1999).
RN   [54]
RP   REVIEW ON FUNCTION IN NETRIN SIGNALING.
RX   PubMed=15725728;
RA   Nikolopoulos S.N., Giancotti F.G.;
RT   "Netrin-integrin signaling in epithelial morphogenesis, axon guidance and
RT   vascular patterning.";
RL   Cell Cycle 4:E131-E135(2005).
RN   [55]
RP   REVIEW ON FUNCTION IN CELL MIGRATION; FOCAL ADHESION TURNOVER AND
RP   ACTIVATION OF SIGNALING PATHWAYS, AND ROLE IN DISEASE.
RX   PubMed=16919435; DOI=10.1016/j.ceb.2006.08.011;
RA   Mitra S.K., Schlaepfer D.D.;
RT   "Integrin-regulated FAK-Src signaling in normal and cancer cells.";
RL   Curr. Opin. Cell Biol. 18:516-523(2006).
RN   [56]
RP   FUNCTION.
RX   PubMed=17968709; DOI=10.1080/15216540701694245;
RA   Vadali K., Cai X., Schaller M.D.;
RT   "Focal adhesion kinase: an essential kinase in the regulation of
RT   cardiovascular functions.";
RL   IUBMB Life 59:709-716(2007).
RN   [57]
RP   REVIEW ON ROLE IN INTEGRIN SIGNALING AND IN REGULATION OF P53/TP53
RP   ACTIVITIES, ROLE IN DISEASE, AND ACTIVITY REGULATION.
RX   PubMed=18677107; DOI=10.4161/cc.6367;
RA   Lim S.T., Mikolon D., Stupack D.G., Schlaepfer D.D.;
RT   "FERM control of FAK function: implications for cancer therapy.";
RL   Cell Cycle 7:2306-2314(2008).
RN   [58]
RP   REVIEW ON FUNCTION IN REGULATION OF RHO FAMILY GTPASE ACTIVITY.
RX   PubMed=19525103; DOI=10.1016/j.ceb.2009.05.006;
RA   Tomar A., Schlaepfer D.D.;
RT   "Focal adhesion kinase: switching between GAPs and GEFs in the regulation
RT   of cell motility.";
RL   Curr. Opin. Cell Biol. 21:676-683(2009).
RN   [59]
RP   REVIEW ON EXPRESSION IN CANCER, AND ROLE IN DISEASE.
RX   PubMed=19224453; DOI=10.14670/hh-24.503;
RA   Golubovskaya V.M., Kweh F.A., Cance W.G.;
RT   "Focal adhesion kinase and cancer.";
RL   Histol. Histopathol. 24:503-510(2009).
RN   [60]
RP   REVIEW ON FUNCTION IN REGULATION OF P53/TP53.
RX   PubMed=20515733; DOI=10.2741/3653;
RA   Golubovskaya V.M., Cance W.;
RT   "Focal adhesion kinase and p53 signal transduction pathways in cancer.";
RL   Front. Biosci. 15:901-912(2010).
RN   [61]
RP   REVIEW ON ROLE IN DEVELOPMENT.
RX   PubMed=20552554; DOI=10.14670/hh-25.1039;
RA   Chatzizacharias N.A., Kouraklis G.P., Theocharis S.E.;
RT   "The role of focal adhesion kinase in early development.";
RL   Histol. Histopathol. 25:1039-1055(2010).
RN   [62]
RP   REVIEW ON FUNCTION IN INTEGRIN SIGNALING AND ACTIVATION OF DOWNSTREAM
RP   SIGNALING PATHWAYS.
RX   PubMed=20101634; DOI=10.1002/iub.303;
RA   Guan J.L.;
RT   "Integrin signaling through FAK in the regulation of mammary stem cells and
RT   breast cancer.";
RL   IUBMB Life 62:268-276(2010).
RN   [63]
RP   FUNCTION, AND SIGNALING.
RX   PubMed=20332118; DOI=10.1242/jcs.045112;
RA   Schaller M.D.;
RT   "Cellular functions of FAK kinases: insight into molecular mechanisms and
RT   novel functions.";
RL   J. Cell Sci. 123:1007-1013(2010).
RN   [64]
RP   REVIEW ON FUNCTION; SUBUNIT; PHOSPHORYLATION; ACTIVITY REGULATION AND ROLE
RP   IN DISEASE.
RX   PubMed=21482413; DOI=10.1016/b978-0-12-386041-5.00005-4;
RA   Hall J.E., Fu W., Schaller M.D.;
RT   "Focal adhesion kinase: exploring Fak structure to gain insight into
RT   function.";
RL   Int. Rev. Cell Mol. Biol. 288:185-225(2011).
RN   [65]
RP   INTERACTION WITH MISP.
RX   PubMed=23509069; DOI=10.1083/jcb.201207050;
RA   Zhu M., Settele F., Kotak S., Sanchez-Pulido L., Ehret L., Ponting C.P.,
RA   Goenczy P., Hoffmann I.;
RT   "MISP is a novel Plk1 substrate required for proper spindle orientation and
RT   mitotic progression.";
RL   J. Cell Biol. 200:773-787(2013).
RN   [66]
RP   SUBUNIT.
RX   PubMed=29069646; DOI=10.1159/000484298;
RA   Rui Y.N., Xu Z., Fang X., Menezes M.R., Balzeau J., Niu A., Hagan J.P.,
RA   Kim D.H.;
RT   "The Intracranial Aneurysm Gene THSD1 Connects Endosome Dynamics to Nascent
RT   Focal Adhesion Assembly.";
RL   Cell. Physiol. Biochem. 43:2200-2211(2017).
RN   [67]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=31630787; DOI=10.1016/j.ajhg.2019.09.022;
RA   Wallmeier J., Frank D., Shoemark A., Noethe-Menchen T., Cindric S.,
RA   Olbrich H., Loges N.T., Aprea I., Dougherty G.W., Pennekamp P., Kaiser T.,
RA   Mitchison H.M., Hogg C., Carr S.B., Zariwala M.A., Ferkol T., Leigh M.W.,
RA   Davis S.D., Atkinson J., Dutcher S.K., Knowles M.R., Thiele H.,
RA   Altmueller J., Krenz H., Woeste M., Brentrup A., Ahrens F., Vogelberg C.,
RA   Morris-Rosendahl D.J., Omran H.;
RT   "De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with
RT   Hydrocephalus and Randomization of Left/Right Body Asymmetry.";
RL   Am. J. Hum. Genet. 105:1030-1039(2019).
RN   [68]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 891-1052, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=12005431; DOI=10.1016/s0969-2126(02)00717-7;
RA   Arold S.T., Hoellerer M.K., Noble M.E.;
RT   "The structural basis of localization and signaling by the focal adhesion
RT   targeting domain.";
RL   Structure 10:319-327(2002).
RN   [69]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 411-686 IN COMPLEX WITH ATP.
RX   PubMed=12467573; DOI=10.1016/s0969-2126(02)00907-3;
RA   Nowakowski J., Cronin C.N., McRee D.E., Knuth M.W., Nelson C.G.,
RA   Pavletich N.P., Rogers J., Sang B.C., Scheibe D.N., Swanson R.V.,
RA   Thompson D.A.;
RT   "Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases
RT   from nanovolume crystallography.";
RL   Structure 10:1659-1667(2002).
RN   [70]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 892-1052 IN COMPLEX WITH PXN, AND
RP   INTERACTION WITH PXN.
RX   PubMed=14527389; DOI=10.1016/j.str.2003.08.010;
RA   Hoellerer M.K., Noble M.E., Labesse G., Campbell I.D., Werner J.M.,
RA   Arold S.T.;
RT   "Molecular recognition of paxillin LD motifs by the focal adhesion
RT   targeting domain.";
RL   Structure 11:1207-1217(2003).
RN   [71]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 414-689 IN COMPLEX WITH
RP   INHIBITOR, CATALYTIC ACTIVITY, AND AUTOPHOSPHORYLATION.
RX   PubMed=18339875; DOI=10.1158/0008-5472.can-07-5155;
RA   Roberts W.G., Ung E., Whalen P., Cooper B., Hulford C., Autry C.,
RA   Richter D., Emerson E., Lin J., Kath J., Coleman K., Yao L.,
RA   Martinez-Alsina L., Lorenzen M., Berliner M., Luzzio M., Patel N.,
RA   Schmitt E., LaGreca S., Jani J., Wessel M., Marr E., Griffor M., Vajdos F.;
RT   "Antitumor activity and pharmacology of a selective focal adhesion kinase
RT   inhibitor, PF-562,271.";
RL   Cancer Res. 68:1935-1944(2008).
RN   [72]
RP   X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF 891-1052 IN COMPLEX WITH CD4,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CD4.
RX   PubMed=18078954; DOI=10.1016/j.jmb.2007.11.040;
RA   Garron M.L., Arthos J., Guichou J.F., McNally J., Cicala C., Arold S.T.;
RT   "Structural basis for the interaction between focal adhesion kinase and
RT   CD4.";
RL   J. Mol. Biol. 375:1320-1328(2008).
RN   [73]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-292; GLN-292; ALA-793; GLU-1030 AND
RP   GLU-1044.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q05397-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q05397-2; Sequence=VSP_004967, VSP_004968, VSP_004969,
CC                                  VSP_004970;
CC       Name=3;
CC         IsoId=Q05397-3; Sequence=VSP_004967, VSP_004968, VSP_004969,
CC                                  VSP_004973, VSP_004974;
CC       Name=4;
CC         IsoId=Q05397-4; Sequence=VSP_004967, VSP_004968, VSP_004969,
CC                                  VSP_004971, VSP_004972;
CC       Name=5;
CC         IsoId=Q05397-5; Sequence=VSP_042169, VSP_042170;
CC       Name=6; Synonyms=FRNK;
CC         IsoId=Q05397-6; Sequence=VSP_042168;
CC       Name=7;
CC         IsoId=Q05397-7; Sequence=VSP_057268;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   ProteomicsDB; 58321; -.
DR   Proteomes; UP000005640; Chromosome 8.
PE   1: Evidence at protein level;
SQ   SEQUENCE   879 AA;  99358 MW;  64783EFF1FF4FCCB CRC64;
     MSDYWVVGKK SNYEVLEKDV GLKRFFPKSL LDSVKAKTLR KLIQQTFRQF ANLNREESIL
     KFFEILSPVY RFDKECFKCA LGSSWIISVE LAIGPEEGIS YLTDKGCNPT HLADFTQVQT
     IQYSNSEDKD RKGMLQLKIA GAPEPLTVTA PSLTIAENMA DLIDGYCRLV NGTSQSFIIR
     PQKEGERALP SIPKLANSEK QGMRTHAVSV SETDDYAEII DEEDTYTMPS TRDYEIQRER
     IELGRCIGEG QFGDVHQGIY MSPENPALAV AIKTCKNCTS DSVREKFLQE ACHYTSLHWN
     WCRYISDPNV DACPDPRNAE LTMRQFDHPH IVKLIGVITE NPVWIIMELC TLGELRSFLQ
     VRKYSLDLAS LILYAYQLST ALAYLESKRF VHRDIAARNV LVSSNDCVKL GDFGLSRYME
     DSTYYKASKG KLPIKWMAPE SINFRRFTSA SDVWMFGVCM WEILMHGVKP FQGVKNNDVI
     GRIENGERLP MPPNCPPTLY SLMTKCWAYD PSRRPRFTEL KAQLSTILEE EKAQQEERMR
     MESRRQATVS WDSGGSDEAP PKPSRPGYPS PRSSEGFYPS PQHMVQTNHY QVSGYPGSHG
     ITAMAGSIYP GQASLLDQTD SWNHRPQEIA MWQPNVEDST VLDLRGIGQV LPTHLMEERL
     IRQQQEMEED QRWLEKEERF LIGNQHIYQP VGKPDPAAPP KKPPRPGAPG HLGSLASLSS
     PADSYNEGVK LQPQEISPPP TANLDRSNDK VYENVTGLVK AVIEMSSKIQ PAPPEEYVPM
     VKEVGLALRT LLATVDETIP LLPASTHREI EMAQKLLNSD LGELINKMKL AQQYVMTSLQ
     QEYKKQMLTA AHALAVDAKN LLDVIDQARL KMLGQTRPH
//
